Onyx Pharmaceuticals, Inc. (ONXX) Income Statement

Click line-items for a historical chart and %

Revenue from collaboration agreement	81.83M
Total revenue	153.03M
Research and development	102.76M
Selling, general and administrative	87.51M
Contingent consideration
Lease termination exit cost
Total operating expenses	200.56M
Loss from operations	-47.53M
Investment income, net	558K
Interest expense	-5.71M
Other expense	-464K
Loss before provision (benefit) for income taxes
Provision (benefit) for income taxes
Net loss	-53.17M
Basic net loss per share
Diluted net loss per share
Shares used in computing basic net loss per share
Shares used in computing diluted net loss per share

Entities mentioned with ONXX

View All Entities